Predictions
Inotiv Inc.
Start price
Target price
Perf. (%)
€13.40
01.05.22
01.05.22
-
01.05.23
01.05.23
-63.13%
24.04.23
24.04.23
Probably not worthwhile Investment
Gritstone Oncology Inc
Start price
Target price
Perf. (%)
€2.52
28.04.22
28.04.22
-
28.04.23
28.04.23
-2.36%
30.04.22
30.04.22
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.37
28.04.22
28.04.22
€2.00
28.04.23
28.04.23
0.74%
03.08.22
03.08.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Teladoc Health Inc
Start price
Target price
Perf. (%)
€30.77
28.04.22
28.04.22
€25.00
28.04.23
28.04.23
19.70%
03.05.22
03.05.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Johnson & Johnson
Start price
Target price
Perf. (%)
€174.42
27.04.22
27.04.22
€190.00
27.04.23
27.04.23
-15.38%
27.04.23
27.04.23
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€48.92
25.04.22
25.04.22
€120.00
03.02.25
03.02.25
-9.22%
16.08.24
16.08.24
Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€233.45
25.04.22
25.04.22
€250.00
25.04.23
25.04.23
14.61%
26.04.23
26.04.23
Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
Myovant Sciences Ltd
Start price
Target price
Perf. (%)
€8.69
22.04.22
22.04.22
-
22.04.23
22.04.23
3.54%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
CEL-SCI Corp.
Start price
Target price
Perf. (%)
€2.91
21.04.22
21.04.22
-
21.04.23
21.04.23
-4.78%
01.05.22
01.05.22
Risky Investment
Voyager Therapeutics Inc
Start price
Target price
Perf. (%)
€6.60
21.04.22
21.04.22
-
21.04.23
21.04.23
4.15%
01.05.22
01.05.22
Risky Investment
Nektar Therapeutics
Start price
Target price
Perf. (%)
€4.42
19.04.22
19.04.22
-
19.04.23
19.04.23
-2.94%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Newegg Commerce Inc.
Start price
Target price
Perf. (%)
€5.95
19.04.22
19.04.22
€11.00
19.04.23
19.04.23
0.00%
02.05.22
02.05.22
Could be very worthwhile Investment >20% year
Curis Inc.
Start price
Target price
Perf. (%)
€1.14
19.04.22
19.04.22
-
19.04.23
19.04.23
-21.19%
01.05.22
01.05.22
Risky Investment
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.99
19.04.22
19.04.22
-
12.04.24
12.04.24
-68.19%
12.04.24
12.04.24
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.70
18.04.22
18.04.22
-
18.04.23
18.04.23
-3.95%
30.04.22
30.04.22
Could be very worthwhile Investment >20% year
Inovio Pharma
Start price
Target price
Perf. (%)
€3.05
12.04.22
12.04.22
€1.60
12.04.23
12.04.23
-30.60%
03.08.22
03.08.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Myovant Sciences Ltd
Start price
Target price
Perf. (%)
€9.86
12.04.22
12.04.22
-
12.04.23
12.04.23
-0.02%
16.04.22
16.04.22
Could be worthwhile Investment >10% per year
Corcept Therapeutics Inc.
Start price
Target price
Perf. (%)
€21.85
12.04.22
12.04.22
-
12.04.23
12.04.23
-9.84%
12.04.23
12.04.23
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.86
12.04.22
12.04.22
-
12.04.23
12.04.23
-23.60%
12.04.23
12.04.23
Novavax Inc.
Start price
Target price
Perf. (%)
€52.93
11.04.22
11.04.22
€40.00
11.04.23
11.04.23
4.10%
03.05.22
03.05.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Affimed N.V.
Start price
Target price
Perf. (%)
€4.75
11.04.22
11.04.22
-
11.04.23
11.04.23
-41.07%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.16
09.04.22
09.04.22
-
09.04.23
09.04.23
0.00%
18.04.22
18.04.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Pfizer Inc.
Start price
Target price
Perf. (%)
€50.65
07.04.22
07.04.22
€56.00
07.04.23
07.04.23
-24.58%
08.04.23
08.04.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€15.54
07.04.22
07.04.22
-
07.04.23
07.04.23
-9.24%
18.04.22
18.04.22
Risky Investment
Gensight Biologics SA
Start price
Target price
Perf. (%)
€2.34
07.04.22
07.04.22
-
07.04.23
07.04.23
-1.02%
08.04.23
08.04.23
Could be worthwhile Investment >10% per year